CHO Pharma, Inc. (TPEX:6586)
Taiwan · Delayed Price · Currency is TWD 104.00
-1.00 (-0.95%)
Oct 28, 2026, 1:58 PM CST
CHO Pharma Market Cap
CHO Pharma has a market cap or net worth of 22.26 billion as of October 28, 2026. It is the 12,457th most valuable company in the world and the 410th biggest in Taiwan. Its market cap has increased by 192.96% in one year.
Market Cap
22.26B
Enterprise Value
20.30B
Revenue
1.71M
Global Rank
Country Rank
#410 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since September 27, 2017, CHO Pharma's market cap has increased from 15.00B to 22.26B, an increase of 48.38%. That is a compound annual growth rate of 4.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 22.26B | 270.11% |
| Dec 31, 2025 | 6.01B | -45.44% |
| Dec 31, 2024 | 11.02B | -25.68% |
| Dec 29, 2023 | 14.83B | -41.16% |
| Dec 30, 2022 | 25.20B | 64.15% |
| Dec 30, 2021 | 15.35B | 235.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 23.09B |
| Sunmax Biotechnology | 21.54B |
| Medigen Vaccine Biologics | 16.77B |
| TaiMed Biologics | 16.69B |
| Ever Supreme Bio Technology | 15.31B |
| EirGenix | 14.84B |
| Steminent Biotherapeutics | 14.50B |
| Gongwin Biopharm Holdings | 14.23B |